Advertisement

Long term follow-up of scoliosis progression in type II SMA patients

Published:November 16, 2022DOI:https://doi.org/10.1016/j.nmd.2022.11.004

      Highlights

      • The aim was to evaluate scoliosis onset and progression in untreated type II SMA patients.
      • The mean annual rate of increase of scoliosis angle was 5.63 (95%CI: 4.74–6.52).
      • The progression of scoliois angles was related to different variables.
      • Angles progressively increased with decreasing HFMSE scores or increasing age.
      • Our results confirm the progression of scoliosis in type II SMA.

      Abstract

      The aim of this study is to retrospectively assess onset and progression of scoliosis in type II SMA patients not treated with the approved disease modifying treatments. Scoliosis was evaluated by measuring the scoliosis angle on X-ray obtained in the anteroposterior view in sitting position (Cobb's angle method).
      Eighty-four patients had at least one assessment of scoliosis angle (287 assessments). There was a positive correlation between age and scoliosis angles (p<0.001) with a progressive increase of scoliosis with age. When subdividing the population by HFMSE score (<10; 11–22;> 22), there was a progressive increase in scoliosis angles with decreasing HFMSE scores. The difference between HFMSE categories was significant (p<0.001). Fifty-four patients had at least two assessments at 6-month distance and were retained for the longitudinal analysis. Using a mixed model, age, functional status and scoliosis angle at baseline were predictive on scoliosis progression. The mean annual rate of increase of scoliosis angle was 5.63 (95%CI: 4.74–6.52).
      Our results confirm the progression of scoliosis in untreated type II SMA providing details of the progression in relation to different variables. With different therapeutical options being available in many countries, our findings will provide reference data for establishing possible differences in the trajectories of progression with treated type II individuals.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Neuromuscular Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Granata C.
        • Cervellati S.
        • Ballestrazzi A.
        • Corbascio M.
        • Merlini L.
        Spine surgery in spinal muscular atrophy: long-term results.
        Neuromuscul Disord. 1993; 3: 207-215
        • Merlini L.
        • Granata C.
        • Bonfiglioli S.
        • Marini M.L.
        • Cervellati S.
        • Savini R.
        Scoliosis in spinal muscular atrophy: natural history and management.
        Dev Med Child Neurol. 1989; 31: 501-508
        • Rodillo E.
        • Marini M.L.
        • Heckmatt J.Z.
        • Dubowitz V.
        Scoliosis in spinal muscular atrophy: review of 63 cases.
        J Child Neurol. 1989; 4: 118-123
        • Riddick M.F.
        • Winter R.B.
        • Lutter L.D.
        Spinal deformities in patients with spinal muscle atrophy: a review of 36 patients.
        Spine (Phila Pa 1976). 1982; 7: 476-483
        • Wijngaarde C.A.
        • Stam M.
        • Otto L.A.M.
        • van Eijk R.P.A.
        • Cuppen I.
        • Veldhoen E.S.
        • et al.
        Population-based analysis of survival in spinal muscular atrophy.
        Neurology. 2020; 94: e1634-e1e44
        • Wijngaarde C.A.
        • Veldhoen E.S.
        • van Eijk R.P.A.
        • Stam M.
        • Otto L.A.M.
        • Asselman F.L.
        • et al.
        Natural history of lung function in spinal muscular atrophy.
        Orphanet J Rare Dis. 2020; 15: 88
        • Messina S.
        • Pane M.
        • De Rose P.
        • Vasta I.
        • Sorleti D.
        • Aloysius A.
        • et al.
        Feeding problems and malnutrition in spinal muscular atrophy type II.
        Neuromuscul Disord. 2008; 18: 389-393
        • Mercuri E.
        • Finkel R.S.
        • Muntoni F.
        • Wirth B.
        • Montes J.
        • Main M.
        • et al.
        Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.
        Neuromuscul Disord. 2017;
        • Wijngaarde C.A.
        • Brink R.C.
        • de Kort F.A.S.
        • Stam M.
        • Otto L.A.M.
        • Asselman F.L.
        • et al.
        Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy.
        Neurology. 2019; 93: e149-ee58
        • Mercuri E.
        • Darras B.T.
        • Chiriboga C.A.
        • Day J.W.
        • Campbell C.
        • Connolly A.M.
        • et al.
        Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
        N Engl J Med. 2018; 378: 625-635
        • Mercuri E.
        • Deconinck N.
        • Mazzone E.S.
        • Nascimento A.
        • Oskoui M.
        • Saito K.
        • et al.
        Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.
        Lancet Neurol. 2022; 21: 42-52
        • Audic F.
        • de la Banda M.G.G.
        • Bernoux D.
        • Ramirez-Garcia P.
        • Durigneux J.
        • Barnerias C.
        • et al.
        Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study.
        Orphanet J Rare Dis. 2020; 15: 148
        • Chacko A.
        • Sly P.D.
        • Ware R.S.
        • Begum N.
        • Deegan S.
        • Thomas N.
        • et al.
        Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1-3.
        Thorax. 2022; 77: 40-46
        • Coratti G.
        • Cutrona C.
        • Pera M.C.
        • Bovis F.
        • Ponzano M.
        • Chieppa F.
        • et al.
        Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis.
        Orphanet J Rare Dis. 2021; 16: 430
        • Konersman C.G.
        • Ewing E.
        • Yaszay B.
        • Naheedy J.
        • Murphy S.
        • Skalsky A
        Nusinersen treatment of older children and adults with spinal muscular atrophy.
        Neuromuscul Disord. 2021; 31: 183-193
        • Maggi L.
        • Bello L.
        • Bonanno S.
        • Govoni A.
        • Caponnetto C.
        • Passamano L.
        • et al.
        Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3.
        J Neurol Neurosurg Psychiatry. 2020; 91: 1166-1174
        • Levine D.B.
        The Hospital for Special Surgery 1955 to 1972: T. Campbell Thompson Serves as Sixth Surgeon-in-Chief 1955-1963 Followed by Robert Lee Patterson, Jr. the Seventh Surgeon-in-Chief 1963-1972.
        HSS J. 2010; 6: 1-13
        • Sucato D.J.
        Spine deformity in spinal muscular atrophy.
        J Bone Joint Surg Am. 2007; 89 (Suppl): 148-154
        • Mercuri E.
        • Lucibello S.
        • Pera M.C.
        • Carnicella S.
        • Coratti G.
        • de Sanctis R.
        • et al.
        Long-term progression in type II spinal muscular atrophy: a retrospective observational study.
        Neurology. 2019; 93: e1241-e12e7
        • Main M.
        • Kairon H.
        • Mercuri E.
        • Muntoni F.
        The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation.
        Eur J Paediatr Neurol. 2003; 7: 155-159
        • Kaufmann P.
        • McDermott M.P.
        • Darras B.T.
        • Finkel R.S.
        • Sproule D.M.
        • Kang P.B.
        • et al.
        Prospective cohort study of spinal muscular atrophy types 2 and 3.
        Neurology. 2012; 79: 1889-1897
        • Tiziano F.D.
        • Bertini E.
        • Messina S.
        • Angelozzi C.
        • Pane M.
        • D'Amico A.
        • et al.
        The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study.
        Neuromuscul Disord. 2007; 17: 400-403
        • Wadman R.I.
        • Wijngaarde C.A.
        • Stam M.
        • Bartels B.
        • Otto L.A.M.
        • Lemmink H.H.
        • et al.
        Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
        Eur J Neurol. 2018; 25: 512-518